Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building genetic healthcare together: an Australian co-production three-phase mixed-methods research protocol with people with intellectual disability.

BMJ open·2026
Same author

High-Risk Valve-in-Valve TAVR With Chronic Type B Aortic Dissection.

JACC. Case reports·2026
Same author

Training School Staff to Prevent Suicide and Promote Mental Health: Outcomes from Virtual PC CARES at School Intervention.

School mental health·2026
Same author

Post-stroke cognitive decline among women in midlife.

Women's health (London, England)·2026
Same author

Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer.

Cancer cell·2026
Same author

Allostatic Load and Healthcare Access Among Stroke Survivors.

Journal of racial and ethnic health disparities·2026

Related Experiment Video

Updated: Jun 16, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

A system dynamics model for planning cardiovascular disease interventions.

Gary Hirsch1, Jack Homer, Elizabeth Evans

  • 1GBHirsch@comcast.net

American Journal of Public Health
|February 20, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a system dynamics model to help communities plan cardiovascular disease (CVD) prevention programs. The model evaluates interventions to reduce CVD burden effectively using limited resources.

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Experiment Videos

Last Updated: Jun 16, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Area of Science:

  • Public Health
  • Epidemiology
  • Health Systems Research

Background:

  • Cardiovascular disease (CVD) prevention program planning faces resource limitations and complex causal pathways.
  • Identifying high-impact interventions is challenging due to time delays between risk factors and CVD events.

Purpose of the Study:

  • To develop and apply a system dynamics simulation model for evaluating CVD prevention and treatment strategies.
  • To assist a county health department in optimizing resource allocation for maximum CVD burden reduction.

Main Methods:

  • Developed a system dynamics simulation model to track CVD risk factors and their impact over time.
  • Incorporated effects on both first-time and recurrent cardiovascular disease events.
  • Utilized the model to test and evaluate the potential impacts of various intervention strategies.

Main Results:

  • The model successfully tracked the long-term effects of risk factors on CVD incidence.
  • Policy tests demonstrated the model's utility in evaluating intervention effectiveness for reducing county CVD burden.
  • Results provided data-driven insights for strategic planning of community health initiatives.

Conclusions:

  • System dynamics modeling offers a robust framework for planning and evaluating community-based CVD programs.
  • This approach can guide health departments in making informed decisions to mitigate cardiovascular disease.
  • Effective resource allocation for CVD prevention can be achieved through simulation-based policy testing.